Our findings show that GRP78, IRE1α, phospho-JNK and XBP1(s) are robustly upregulated in antiestrogen resistant ER + breast cancer cells in the presence of glutamine but absence of glucose (Figure 8A). The gene discussed is XBP1; the disease is breast carcinoma.